1. A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma. (March 2018) Authors: Cohen, Steven J.; Zalupski, Mark M.; Conkling, Paul; Nugent, Francis; Ma, Wen Wee; Modiano, Manuel; Pascual, Rolan; Lee, Fa Chyi; Wong, Lucas; Hersh, Evan Journal: American journal of clinical oncology Issue: Volume 41:Number 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent Immunotherapy. (14th September 2022) Authors: Kaakour, Dalia; Hagopian, Garo; Lee, Sonia; Lee, Fa Chyi Journal: American journal of clinical oncology Issue: Volume 45:Number 10(2022) Page Start: 410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. INST OX‐05‐024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial. (11th August 2017) Authors: Patt, Yehuda Z.; Murad, Waheed; Fekrazad, Mohammed H.; Baron, Ari D.; Bansal, Pranshu; Boumber, Yanis; Steinberg, Kim; Lee, Sang‐Joon; Bedrick, Ed; Du, Ruofei; Lee, Fa Chyi Journal: Cancer medicine Issue: Volume 6:Number 9(2017:Sep.) Page Start: 2042 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08‐20. (7th July 2017) Authors: Patt, Yehuda; Rojas‐Hernandez, Cristhiam; Fekrazad, Houman Mohammad; Bansal, Pranshu; Lee, Fa Chyi Journal: Oncologist Issue: Volume 22:Number 10(2017) Page Start: 1158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer. (4th December 2017) Authors: Araujo‐Mino, Emilio P.; Patt, Yehuda Z.; Murray‐Krezan, Cristina; Hanson, Joshua A.; Bansal, Pranshu; Liem, Ben J.; Rajput, Ashwani; Fekrazad, M. Houman; Heywood, Glenory; Lee, Fa Chyi Journal: Oncologist Issue: Volume 23:Number 1(2018) Page Start: 2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗